From STAT: Scott Gottlieb, Trump’s pick to lead the FDA, should consider pursuing a stronger warning label for the antidepressant Paxil. Paxil’s label currently does not indicate any risk of suicidal behavior for anyone over 25, even though there is scientific evidence that such a risk is real.
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.
RELATED ARTICLESMORE FROM AUTHOR
This guy is probably locked into some kind of pro-business outlook. You should probably have also told him that you can’t sell more antidepressants to dead patients.